NEW YORK, Nov. 19, 2024 /PRNewswire/ — Report on how AI is driving market transformation – The global microbiomes market size is estimated to grow by USD 1.13 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 22.67% during the forecast period. Increasing prevalence of diseases is driving market growth, with a trend towards significant number of collaborations for developing microbiome therapeutics. However, challenges related to manufacturing and formulation of microbiome therapeutic products poses a challenge.Key market players include AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., Vedanta Biosciences Inc., YSOPIA Bioscience, and THERIVA BIOLOGICS INC..
AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest …